CA9 and prostate adenocarcinoma: We tested 30 prostate adenocarcinomas for CA IX expression, selected from a wider series previously tested for BAG3 expression [105], upon stratification into three groups, according to the combined Gleason score: low-grade (n=10), intermediate-grade (n=12) and high-grade carcinomas (n=8).